Latest news
Google calls for patient involvement
Posted: Wednesday 24 August 2016
Patients are being invited to Google's offices in Kings Cross, London for the first public meeting about a new medical research partnership with Google DeepMind and Moorfields Eye Hospital.The partnership could revolutionise the way professionals carry o…
Find out more
Clinical trials in Scotland for potential new treatment for dry AMD
Posted: Wednesday 17 August 2016
A drug which could become the first treatment for dry age-related macular degeneration is being trialled in Scotland for the first time.
Find out more
Handheld OCT scanner could reduce waiting times
Posted: Wednesday 17 August 2016
A new handheld OCT, which could help to address long hospital waiting times, could be ready by 2018.
Find out more
A successful Macular Week 2016!
Posted: Wednesday 6 July 2016
A huge thank you to everyone who helped us mark Macular Week 2016.
Find out more
Health Talk seeks genomic research participants
Posted: Thursday 16 June 2016
Health Talk, which provides free information about health issues by sharing people's real-life experiences, is looking to talk to people who have been invited to take part in the Genome 100,000 Project.
Find out more
Masquerade ball to raise funds and awareness of macular disease
Posted: Friday 27 May 2016
A Macular Society member has organised a masquerade ball to help raise funds for the Society and awareness of macular disease.
Find out more
Revolutionary treatment becomes available on NHS in Manchester
Posted: Thursday 26 May 2016
Manchester Royal Eye Hospital has become the first NHS hospital in the UK to offer a new telescope implant for end-stage age-related macular degeneration.
Find out more
Wet AMD treatment news from ARVO2016
Posted: Wednesday 4 May 2016
Graybug Vision, Inc., a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases including wet age-related macular degeneration (AMD) and glaucoma, today announced that data from a preclinical …
Find out more
Age-related macular degeneration before and after the era of anti-VEGF drugs
Posted: Wednesday 4 May 2016
NIH-funded study of Avastin and Lucentis examines their effects at five years.In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better, typically good enough to drive or to read st…
Find out more
Preliminary applications are now invited for 2017 grants
Posted: Friday 29 April 2016
The Macular Society is now accepting preliminary applications for research grants and PhD studentships beginning in 2017.
Find out more
Gene therapy reverses sight loss and is long-lasting
Posted: Thursday 28 April 2016
A genetic therapy has improved the vision of patients who would otherwise have gone blind.A clinical study has shown that the improvement is long-lasting and so the therapy is suitable to be offered as a treatment.The researchers will apply for approval …
Find out more
Aardman helps us raise plight of macular degeneration
Posted: Friday 22 April 2016
Aardman Animations, the creators of Shaun the Sheep and Wallace and Gromit, have created a new character to help us fight the most common cause of blindness. Mac stars in our short film and has been designed to appeal to all ages and creates an emotional …
Find out more
Get the latest news and advice from the Macular Society
To hear about life-changing research, treatments and tips for living with sight loss, subscribe to our monthly enewsletter today. Together we can Beat Macular Disease.
Sign up to our free email newsletter
